The Dept. of Biochemistry & Biophysics – where SEC means Size Exclusion Chromatography.
Making its way through a bunch of news outlets is the discovery from Dr. Pellois’ lab of a “Trojan Horse” way to deliver protein into a cell without harming it. Read more here: today.agrilife.org-Researchers_discover_Trojan_Horse_method_of_penetrating_cellular_walls_without_harm
Yuan Yang, a graduate student in Dr. Tatyana Igumenova’s laboratory, has been awarded a highly competitive 2-year Predoctoral Fellowship from the American Heart Association. The objective of her research is to understand how the activity of Protein Kinase Calpha, an enzyme involved in progression and development of cardiovascular disease, is regulated by the peptidyl-prolyl isomerase Pin1. Yuan has also delivered a talk on this subject at the 2014 Biophysical Society meeting in San Francisco.
Congratulations to Yuan!
Sara Reardon writes about new interest in phage therapy in the June 3 issue of Nature. Our own Prof. Ry Young, one of the world experts on bacteriophage biology and the founder of the Center for Phage Technology here at Texas A&M is extensively quoted about the potential for phage as a means of combating the resurgence of bacterial infectious diseases as antibiotic resistance spreads across the world. Reardon writes:
Ryland Young, a virologist at Texas A&M University in College Station, attributes the previous lack of Western interest to clinicians’ preference for treating unknown infections with broad-spectrum antibiotics that kill many types of bacterium. Phages, by contrast, kill just one species or strain.
The CPT is working not just on the potential of phage to treat infectious diseases in humans, but also in the plants and animals that are so important to our lives.